BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 2, 2011
View Archived Issues
Autologous hematopoietic stem cell therapy successfully treats children with ADA-SCID
Read More
Sanofi affiliate files MAA for tesamorelin in Brazil
Read More
Study links SNPs to secondary malignant neoplasms due to radiation for pediatric Hodgkin's lymphoma
Read More
Phosphodiesterase 5 inhibitor suppresses bladder mechanosensory activity in vivo
Read More
New 11-beta-HSD1 inhibitor has potent preclinical activity
Read More
Merck & Co. presents new gamma-secretase inhibitor as clinical candidate in Alzheimer's disease
Read More
LIST trial compares long-term effects of imidafenacin and solifenacin in OAB
Read More
Cambridge Enterprise discloses novel serotonin 5-HT1B receptor modulators
Read More
New macrocyclic coagulation factor XIa inhibitors synthesized at Bristol-Myers Squibb
Read More
Novel carbonic anhydrase inhibitors patented by European investigators
Read More
New peptidyl-prolyl cis-trans isomerase D inhibitors presented by Biotica
Read More
NattoPharma prepares new vitamin K analogues
Read More
New approval for Remicade in Canada
Read More
FDA accepts avanafil NDA
Read More
Eisai terminates development of extended-release rabeprazole sodium formulation
Read More
STADA and Gedeon Richter sign agreement for rituximab and trastuzumab biosimilars
Read More
Ardelyx closes series B financing for RDX-5791 development
Read More
AstraZeneca reports topline data from phase IIIb SATURN trial
Read More
New phase II study evaluates Dr. Reddy's DRL-17822
Read More
FDA issues drug safety communication regarding Saphris
Read More
DSMB recommends progression to higher dose in ReN-001 stem cell trial for stroke
Read More
Chugai in-licenses Japanese rights to two monoclonal antibodies
Read More
Synageva and Mitsubishi Tanabe Pharma sign research and development partnership
Read More
FDA issues update to Reclast drug label regarding risk of kidney failure
Read More
AnaptysBio completes generation of therapeutic antibodies for partner
Read More
Pevion grants CSL right of first refusal to exclusive license of candidiasis vaccine
Read More
